STRZ:NASDAQStarz Entertainment Corp. Analysis
Data as of 2026-05-03 - not real-time
$19.75
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Starz (STRZ) is trading at $19.75, comfortably above its 20‑day ($17.12), 50‑day ($14.24) and 200‑day ($12.66) simple moving averages, signaling a bullish price trend. However, the 14‑day RSI of 70.3 places the stock in overbought territory and the MACD histogram has turned negative, hinting at a possible short‑term pull‑back. Volume has been decreasing, and the 30‑day volatility is extremely high at 74%, while a beta of 1.17 suggests the stock moves more aggressively than the market. Market sentiment is very positive, reflected by an “Extreme Greed” reading on the Fear & Greed Index and analyst consensus at “Buy” with a mean target of $20.75.
Fundamentally, STRZ is struggling: revenue fell 6.3% YoY, the company posted a –12% profit margin and a trailing EPS of –$16.80, and it carries a heavy debt load ($742 M) with a debt‑to‑equity ratio over 115%. The balance sheet shows a low price‑to‑book of 0.51 and a price‑to‑sales of 0.26, indicating the market is valuing the firm well below its asset base, but free cash flow is zero and operating cash flow is modest. Upcoming Q1 2026 earnings on May 7 will be a key catalyst to assess whether the revenue decline is stabilizing. The combination of bullish technicals, extreme market optimism, and deep valuation discounts is tempered by high leverage, negative earnings, and pronounced price volatility.
Fundamentally, STRZ is struggling: revenue fell 6.3% YoY, the company posted a –12% profit margin and a trailing EPS of –$16.80, and it carries a heavy debt load ($742 M) with a debt‑to‑equity ratio over 115%. The balance sheet shows a low price‑to‑book of 0.51 and a price‑to‑sales of 0.26, indicating the market is valuing the firm well below its asset base, but free cash flow is zero and operating cash flow is modest. Upcoming Q1 2026 earnings on May 7 will be a key catalyst to assess whether the revenue decline is stabilizing. The combination of bullish technicals, extreme market optimism, and deep valuation discounts is tempered by high leverage, negative earnings, and pronounced price volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Upcoming Q1 earnings release providing near‑term catalyst
- Price positioned above key moving averages indicating bullish momentum
- Overbought RSI and bearish MACD divergence suggest limited upside risk
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt load and negative profitability constrain earnings recovery
- Volatile price action and decreasing volume raise execution risk
- Valuation discount to book offers upside if operational turnaround occurs
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Sustained revenue decline and lack of free cash flow limit growth prospects
- Deep price‑to‑book discount may appeal value investors over a longer horizon
- Industry competitive dynamics and content licensing costs pose ongoing challenges
Key Metrics & Analysis
Financial Health
Revenue Growth-6.30%
Profit Margin-12.02%
P/E Ratio-45.1
Debt/Equity114.92
P/B Ratio0.5
Op. Cash Flow$23.9M
Industry P/E18.9
Technical Analysis
TrendBullish
RSI70.3
Support$12.07
Resistance$20.63
MA 20$17.12
MA 50$14.24
MA 200$12.66
MACDBearish
VolumeDecreasing
Fear & Greed Index91.09
Valuation
Target Price$20.75
Upside/Downside5.06%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.17
Volatility74.18%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.